4.6 Article

The effect of a lozenge combining prebiotic arginine and probiotics on caries increment in children during 10-12 months, a randomized clinical trial

Journal

JOURNAL OF DENTISTRY
Volume 135, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jdent.2023.104599

Keywords

Randomized clinical trial; Caries; Probiotics; Arginine; Synbiotic; Pediatric dentistry

Ask authors/readers for more resources

This study investigated the effects of using a lozenge containing arginine and probiotics for 10-12 months on caries increment, gingivitis, and plaque occurrence in children aged 5-9 years. The results showed that the lozenge significantly reduced the caries increment, but had no significant effect on plaque or gingivitis occurrence.
Objectives: To investigate the effect of daily use of a lozenge containing arginine and probiotics for 10-12 months on caries increment, gingivitis-and plaque occurrence in children aged 5-9 years. Methods: In this placebo-controlled, double-blinded, parallel-grouped randomized clinical trial, 343 children were randomly assigned to one of the study arms (1:1). The intervention group (n = 172) received a lozenge containing Lacticaseibacillus rhamnosus, LGG & REG; (DSM33156), Lactobacillus paracasei subsp. paracasei, L. CASEI 431 & REG; (DSM33451) and prebiotic (arginine 2%). The placebo group (n = 171) received an identical lozenge without arginine or probiotics. Primary canines and molars, and permanent first molars were examined clinically (d/D= ICDAS1-6) and radiographically (d/D = R1-6) at baseline and follow-up. Missing (m/M), sealed (s/S), and filled (f/F) surfaces (-s/-S) in both dentitions were also included. Utilizing clinical and radiographic scorings, caries experience was classified as dICDAS1-6msf-s (primary teeth), DICDAS1-6MSF-S (permanent teeth), d/ DICDAS1-6 m/M-s/S-f/F-s/S (mixed dentition). A weighted and an unweighted score system was applied. Results: The study was completed by 288 children. The dropout rate was 15%. The increase in & UDelta;mean dIC-DAS3-6msf-s and & UDelta;mean d/DICDAS3-6m/M-s/S-f/F-s/S was lower in the intervention group (p = 0.007). No dif-ferences were found for gingivitis-and plaque occurrence. No product-related side effects were reported. This study followed ICH-GCP including external monitoring. Conclusion: Daily consumption of a lozenge containing prebiotic arginine and two strains of probiotics showed safe use and statistically significantly reduction in caries incrementbut no effect on the mean plaque or gingivitis occurrence in children. The use of a lozenge with arginine and probiotics combined has a promising potential as a supplementary tool for future management of caries. www.ClinicalTrials.gov (NCT03928587). Clinical significance: The combination of prebiotic arginine and probiotics shows clinical potential as a supple-mentary approach to toothbrushing with fluoride toothpaste in managing caries increment in children. A new era in the management of caries may be emerging.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available